MD Medical Group announces senior management and Board of Directors changes

09 September 2019, Moscow - MD Medical Group Investments Plc (“MD Medical Group”, “MDMG” or the “Company” – LSE: MDMG), a leading Russian private healthcare provider, today announces changes in its senior management team and Board of Directors.

Mrs Liubov Malyarevskaya has stepped down as an Independent Non-Executive Director on 09 September 2019. The Company expresses its gratitude to Liubov Malyarevskaya for her work as a member of the Board and contribution to the development of the Company.

Mr Vadim Vlasov has joined the Company as deputy CEO in charge of development. Vadim Vlasov has graduated from the Moscow Aviation Institute, held various posts in the aerospace industry, was head of the representative office of the Airbus corporation in Russia, later acquired vast experience in the medical and pharmaceutical businesses. From 2010 to 2019 Vadim Vlasov served as Country President of Novartis Group of Companies in Russia, Regional Director Country Management CEE and CIS, Chairman of the Board of Directors of Association of International Pharmaceutical Manufacturers (AIPM).